Love can build a bridge. Looking for individuals to help with construction. Contact your local We are ready centers to join.

Small Pox has always been the next step.

FDA approved a pill for small pox in 2018.
Yes a pill for a disease that is eradicated in the U.S.
Their excuse is just in case of bio-terrorism.
A company called SIGA got the call and has a contract with BARDA (The Biomedical Advanced Research and Development Authority) to supply the drug.

Here is the catch though and it's freaking HUGE.
"The efficacy of TPOXX may be reduced in immunocompromised
patients." A.K.A. everyone with a covid vax.
It gets much worse.
A dedicated drug-drug interaction study determined that drug interactions exist for co-administration of repaglinide and midazolam.
Wouldn't you know that both of those drugs are used in a form of a Covid vaccine.

So not only will it not work well but you could have deaths from drug interactions out the wazzu.
BTW SIGA is Agis backward. Agis is a huge elder health network.

This is a set up, it always was. They are trying to sacrifice those you love.
BE VERY AFRAID.

President: Donald J. Trump. The Corp. Never Ever give up. WWG1WG1 And above all Trust God. Pray often.

In response John Qpublic to his Publication

All ya gotta do is watch the weather channel or weather nation. Thats a sure fire bunch of commercials. All kinds of vaxs coming out.
Wonder why.. T-cells are crazy after vax.

God made a perfect system. Anything that was brought into the world after that is disease. God already gave us the abilities to destroy it and they know this so they have to figure out how to short circuit his auto fixes.
I was going to explain but this article covers it so much better than I ever could and it is from the NIH so of course it will explain what they already claim they don't know.

https://www.ncbi.nlm.nih.gov/books/NBK27098/

In response Wlim Elgof to his Publication

Only people mentioned by @Jamesbridgebuilder in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from John Qpublic, click on at the bottom under it